EDTUTC-4 New YorkLog in Sign up

IMRX
Immuneering Corporation Class A Common Stock
stockNASDAQ

At CloseOct 14, 2026 3:59:57 PM EDT

3.43USD-3.652%(-0.13)803,723

Pre-marketOct 14, 2026 8:54:30 AM EDT

3.62USD+1.685%(+0.06)

After-hoursOct 14, 2026 4:51:30 PM EDT

3.3606USD-2.023%(-0.0694)

3.4200Bid3.4400Ask0.0200Spread

Loading…

Loading…

221.59M

Healthcare

Biotechnology

HQ

Cambridge, MA, USA

68

Previous Close

$3.56

Beta

1.17

52-Week High

$8.48 2026-01-07

52-Week Low

$3.55 2026-10-13

SMA 50

$4.58

SMA 200

$4.95

Avg. Vol 10D

775,587

Avg. Vol 30D

730,399

Avg. Vol 90D

941,131

Relative Vol

0.97

64.70M

25.23M

39.00%

15,492,438

Short Interest %

61.41%

24.22

On/Off Exchange

50%/50%

44.27%

Short Vol % (off-exch)

34.48%

5.1000%

150,000

4,502

25,185

67,401

Nov 11, 2026 (27d)

Oct 2, 2026

09:00 AM EDTImmuneering to Present at the 41st Annual Meeting of the Society for Immunotherapy of Cancer (SITC) ·

GlobeNewswire Inc.

Sep 28, 2026

07:30 AM EDTImmuneering Presents Data at 2026 AACR Conference on Pancreatic Cancer Supporting Atebimetinib’s Mechanisms Designed to Extend Survival in Pancreatic Cancer ·

GlobeNewswire Inc.

Sep 24, 2026

07:30 AM EDTImmuneering to Present at the ESMO Congress 2026 ·

GlobeNewswire Inc.

Aug 26, 2026

05:16 PM EDTImmuneering Comments on Today’s FDA Approval in Second-Line Metastatic Pancreatic Cancer, Reiterates Focus on First-Line Patients ·

GlobeNewswire Inc.

IMRX Performance

Period	Price	Date	Change	Beta
1W	3.86	2026-10-07	-11.27%	9.138
1M	4.33	2026-09-14	-20.90%	0.849
3M	5.21	2026-07-14	-34.26%	1.809
6M	5.41	2026-04-14	-36.69%	0.845
1Y	5.96	2025-10-14	-42.53%	1.166
2Y	2.00	2024-10-14	+71.25%	—
5Y	24.01	2021-10-14	-85.73%	1.165

IMRX Stock Summary

Immuneering Corporation Class A Common Stock (NASDAQ:IMRX) stock price today is $3.43, and today's volume is 711,585. IMRX is down 3.792% today. The 30 day average volume is 730,399. IMRX market cap is $221.59M with 64.70M shares outstanding.